Survival of residual neutrophils and accelerated myelopoiesis limit the efficacy of antibody-mediated depletion of Ly-6G+ cells in tumor-bearing mice

Journal of Leukocyte Biology

Volumn 99, Issue 6, 2016, Pages 811-823

  Moses, Katrin ^a   Klein, Johanna C ^a   Männ, Linda ^a   Klingberg, Anika ^a   Gunzer, Matthias ^a   Brandau, Sven ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Extramedullary granulopoiesis; Gr 1 depletion; Head and neck cancer; MDSC; Tumor associated neutrophils

Indexed keywords

ANTIBODY; CD11B ANTIGEN; CHEMOKINE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; LY ANTIGEN; LY6G ANTIGEN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER MODEL; CELL EXPANSION; CELL MATURATION; CONTROLLED STUDY; FLOW CYTOMETRY; GRANULOPOIESIS; HEAD AND NECK CANCER; HISTOPATHOLOGY; MOUSE; MYELOPOIESIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL DIFFERENTIATION; CELL SURVIVAL; HEAD AND NECK TUMOR; METABOLISM; PATHOLOGY; SPLEEN; TUMOR CELL LINE;

ANIMALS; ANTIBODIES; ANTIGENS, CD11B; ANTIGENS, LY; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOKINES; HEAD AND NECK NEOPLASMS; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MYELOPOIESIS; NEUTROPHILS; SPLEEN;

EID: 84971407807     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1HI0715-289R     Document Type: Article

References (63)

1. Musiani, P., Allione, A., Modica, A., Lollini, P. L., Giovarelli, M., Cavallo, F., Belardelli, F., Forni, G., Modesti, A. (1996) Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-a, IFN-g, and TNF-a. Lab. Invest. 74, 146-157.
2. Schmielau, J., Finn, O. J. (2001) Activated granulocytes and granulocytederived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res. 61, 4756-4760.
3. Serafini, P., Borrello, I., Bronte, V. (2006) Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 16, 53-65.
4. Brandau, S., Moses, K., Lang, S. (2013) The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins? Semin. Cancer Biol. 23, 171-182.
5. Lee, M. Y., Liu, C. C., Lottsfeldt, J. L., Judkins, S. A., Howard, G. A. (1987) Production of granulocyte-stimulating and bone cell-modulating activities from a neutrophilia hypercalcemia-inducing murine mammary cancer cell line. Cancer Res. 47, 4059-4065.
6. Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., Calabrese, F., Basso, G., Zanovello, P., Cozzi, E., Mandruzzato, S., Bronte, V. (2010) Tumor-induced tolerance and immune suppression depend on the C/EBPb transcription factor. Immunity 32, 790-802.
7. Cortez-Retamozo, V., Etzrodt, M., Newton, A., Rauch, P. J., Chudnovskiy, A., Berger, C., Ryan, R. J., Iwamoto, Y., Marinelli, B., Gorbatov, R., Forghani, R., Novobrantseva, T. I., Koteliansky, V., Figueiredo, J. L., Chen, J. W., Anderson, D. G., Nahrendorf, M., Swirski, F. K., Weissleder, R., Pittet, M. J. (2012) Origins of tumor-associated macrophages and neutrophils. Proc. Natl. Acad. Sci. U. S. A. 109, 2491-2496.
8. Fridlender, Z. G., Sun, J., Mishalian, I., Singhal, S., Cheng, G., Kapoor, V., Horng, W., Fridlender, G., Bayuh, R., Worthen, G. S., Albelda, S. M. (2012) Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS One 7, e31524.
9. Haverkamp, J. M., Crist, S. A., Elzey, B. D., Cimen, C., Ratliff, T. L. (2011) In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. Eur. J. Immunol. 41, 749-759.
10. Moore, B. B., Arenberg, D. A., Stoy, K., Morgan, T., Addison, C. L., Morris, S. B., Glass, M., Wilke, C., Xue, Y. Y., Sitterding, S., Kunkel, S. L., Burdick, M. D., Strieter, R. M. (1999) Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am. J. Pathol. 154, 1503-1512.
11. Zhou, S. L., Dai, Z., Zhou, Z. J., Wang, X. Y., Yang, G. H., Wang, Z., Huang, X. W., Fan, J., Zhou, J. (2012) Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 56, 2242-2254.
12. Sawanobori, Y., Ueha, S., Kurachi, M., Shimaoka, T., Talmadge, J. E., Abe, J., Shono, Y., Kitabatake, M., Kakimi, K., Mukaida, N., Matsushima, K. (2008) Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111, 5457-5466.
13. Eash, K. J., Greenbaum, A. M., Gopalan, P. K., Link, D. C. (2010) CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J. Clin. Invest. 120, 2423-2431.
14. Jablonska, J., Wu, C. F., Andzinski, L., Leschner, S., Weiss, S. (2014) CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-b. Int. J. Cancer 134, 1346-1358.
15. Highfill, S. L., Cui, Y., Giles, A. J., Smith, J. P., Zhang, H., Morse, E., Kaplan, R. N., Mackall, C. L. (2014) Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy. Sci. Transl. Med. 6, 237ra67.
16. Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., Moses, H. L. (2008) Abrogation of TGF-b signaling in mammary carcinomas recruits Gr-1+ CD11b+ myeloid cells that promote metastasis. Cancer Cell 13, 23-35.
17. Trellakis, S., Bruderek, K., Dumitru, C. A., Gholaman, H., Gu, X., Bankfalvi, A., Scherag, A., Hütte, J., Dominas, N., Lehnerdt, G. F., Hoffmann, T. K., Lang, S., Brandau, S. (2011) Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int. J. Cancer 129, 2183-2193.
18. Trellakis, S., Bruderek, K., Hütte, J., Elian, M., Hoffmann, T. K., Lang, S., Brandau, S. (2013) Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer. Innate Immun. 19, 328-336.
19. Dumitru, C. A., Gholaman, H., Trellakis, S., Bruderek, K., Dominas, N., Gu, X., Bankfalvi, A., Whiteside, T. L., Lang, S., Brandau, S. (2011) Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int. J. Cancer 129, 859-869.
20. Daley, J. M., Thomay, A. A., Connolly, M. D., Reichner, J. S., Albina, J. E. (2008) Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83, 64-70.
21. Dejima, T., Shibata, K., Yamada, H., Hara, H., Iwakura, Y., Naito, S., Yoshikai, Y. (2011) Protective role of naturally occurring interleukin-17Aproducing gd T cells in the lung at the early stage of systemic candidiasis in mice. Infect. Immun. 79, 4503-4510.
22. Carr, K. D., Sieve, A. N., Indramohan, M., Break, T. J., Lee, S., Berg, R. E. (2011) Specific depletion reveals a novel role for neutrophil-mediated protection in the liver during Listeria monocytogenes infection. Eur. J. Immunol. 41, 2666-2676.
23. Ribechini, E., Leenen, P. J., Lutz, M. B. (2009) Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells. Eur. J. Immunol. 39, 3538-3551.
24. Ma, C., Kapanadze, T., Gamrekelashvili, J., Manns, M. P., Korangy, F., Greten, T. F. (2012) Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 92, 1199-1206.
25. Hasenberg, A., Hasenberg, M., Männ, L., Neumann, F., Borkenstein, L., Stecher, M., Kraus, A., Engel, D. R., Klingberg, A., Seddigh, P., Abdullah, Z., Klebow, S., Engelmann, S., Reinhold, A., Brandau, S., Seeling, M., Waisman, A., Schraven, B., Göthert, J. R., Nimmerjahn, F., Gunzer, M. (2015) CatchUp: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes. Nat. Methods 12, 445-452.
26. Olive, P. L., Chaplin, D. J., Durand, R. E. (1985) Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours. Br. J. Cancer 52, 739-746.
27. Williams, R., Lee, D. W., Elzey, B. D., Anderson, M. E., Hostager, B. S., Lee, J. H. (2009) Preclinical models of HPV+ and HPV2 HNSCC in mice: an immune clearance of HPV+ HNSCC. Head Neck 31, 911-918.
28. Leurs, C., Jansen, M., Pollok, K. E., Heinkelein, M., Schmidt, M., Wissler, M., Lindemann, D., Von Kalle, C., Rethwilm, A., Williams, D. A., Hanenberg, H. (2003) Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells. Hum. Gene Ther. 14, 509-519.
29. Trellakis, S., Farjah, H., Bruderek, K., Dumitru, C. A., Hoffmann, T. K., Lang, S., Brandau, S. (2011) Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors. Int. J. Immunopathol. Pharmacol. 24, 683-693.
30. Brandau, S., Jakob, M., Bruderek, K., Bootz, F., Giebel, B., Radtke, S., Mauel, K., Jäger, M., Flohé, S. B., Lang, S. (2014) Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes [published correction in PLoS One (2014); 9:e114201].. PLoS One 9, e106903.
31. Ueha, S., Shand, F. H., Matsushima, K. (2011) Myeloid cell population dynamics in healthy and tumor-bearing mice. Int. Immunopharmacol. 11, 783-788.
32. Tazzyman, S., Barry, S. T., Ashton, S., Wood, P., Blakey, D., Lewis, C. E., Murdoch, C. (2011) Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth. Int. J. Cancer 129, 847-858.
33. Bozic, C. R., Gerard, N. P., von Uexkull-Guldenband, C., Kolakowski, Jr., L. F., Conklyn, M. J., Breslow, R., Showell, H. J., Gerard, C. (1994) The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J. Biol. Chem. 269, 29355-29358.
34. Rovai, L. E., Herschman, H. R., Smith, J. B. (1998) The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J. Leukoc. Biol. 64, 494-502.
35. Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., Kooistra, T., Fingerle-Rowson, G., Ghezzi, P., Kleemann, R., McColl, S. R., Bucala, R., Hickey, M. J., Weber, C. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-596.
36. Youn, J. I., Nagaraj, S., Collazo, M., Gabrilovich, D. I. (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791-5802.
37. Yang, W., Wang, D., Richmond, A. (1999) Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction. J. Biol. Chem. 274, 11328-11333.
38. Fan, G. H., Lapierre, L. A., Goldenring, J. R., Richmond, A. (2003) Differential regulation of CXCR2 trafficking by Rab GTPases. Blood 101, 2115-2124.
39. Suttmann, H., Riemensberger, J., Bentien, G., Schmaltz, D., Stöckle, M., Jocham, D., Böhle, A., Brandau, S. (2006) Neutrophil granulocytes arerequired for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses. Cancer Res. 66, 8250-8257.
40. Terabe, M., Matsui, S., Park, J. M., Mamura, M., Noben-Trauth, N., Donaldson, D. D., Chen, W., Wahl, S. M., Ledbetter, S., Pratt, B., Letterio, J. J., Paul, W. E., Berzofsky, J. A. (2003) Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J. Exp. Med. 198, 1741-1752.
41. Pekarek, L. A., Starr, B. A., Toledano, A. Y., Schreiber, H. (1995) Inhibition of tumor growth by elimination of granulocytes. J. Exp. Med. 181, 435-440.
42. Ren, G., Zhao, X., Wang, Y., Zhang, X., Chen, X., Xu, C., Yuan, Z. R., Roberts, A. I., Zhang, L., Zheng, B., Wen, T., Han, Y., Rabson, A. B., Tischfield, J. A., Shao, C., Shi, Y. (2012) CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFa. Cell Stem Cell 11, 812-824.
43. Morales, J. K., Kmieciak, M., Graham, L., Feldmesser, M., Bear, H. D., Manjili, M. H. (2009) Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells. Cancer Immunol. Immunother. 58, 941-953.
44. Dumitru, C. A., Lang, S., Brandau, S. (2013) Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. Semin. Cancer Biol. 23, 141-148.
45. Shahbazian, L. M., Quinton, L. J., Bagby, G. J., Nelson, S., Wang, G., Zhang, P. (2004) Escherichia coli pneumonia enhances granulopoiesis and the mobilization of myeloid progenitor cells into the systemic circulation. Crit. Care Med. 32, 1740-1746.
46. Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., Albelda, S. M. (2009) Polarization of tumor-associated neutrophil phenotype by TGF-b: “N1” versus “N2” TAN. Cancer Cell 16, 183-194.
47. Cain, D. W., Snowden, P. B., Sempowski, G. D., Kelsoe, G. (2011) Inflammation triggers emergency granulopoiesis through a densitydependent feedback mechanism. PLoS One 6, e19957.
48. Brown, C. R., Blaho, V. A., Loiacono, C. M. (2004) Treatment of mice with the neutrophil-depleting antibody RB6-8C5 results in early development of experimental Lyme arthritis via the recruitment of Gr-12 polymorphonuclear leukocyte-like cells. Infect. Immun. 72, 4956-4965.
49. Abbitt, K. B., Cotter, M. J., Ridger, V. C., Crossman, D. C., Hellewell, P. G., Norman, K. E. (2009) Antibody ligation of murine Ly-6G induces neutropenia, blood flow cessation, and death via complement-dependent and independent mechanisms. J. Leukoc. Biol. 85, 55-63.
50. Bucher, K., Schmitt, F., Autenrieth, S. E., Dillmann, I., Nürnberg, B., Schenke-Layland, K., Beer-Hammer, S. (2015) Fluorescent Ly6G antibodies determine macrophage phagocytosis of neutrophils and alter the retrieval of neutrophils in mice. J. Leukoc. Biol. 98, 365-372.
51. Dzhagalov, I., St John, A., He, Y. W. (2007) The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. Blood 109, 1620-1626.
52. Goñi, O., Alcaide, P., Fresno, M. (2002) Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1+)CD11b+immature myeloid suppressor cells. Int. Immunol. 14, 1125-1134.
53. Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., Kast, W. M. (2001) Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J. Immunol. 166, 5398-5406.
54. Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., Gabrilovich, D. I. (2001) Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166, 678-689.
55. Ochoa, A. C., Zea, A. H., Hernandez, C., Rodriguez, P. C. (2007) Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin. Cancer Res. 13, 721s-726s.
56. Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J. I., Cheng, P., Cho, H. I., Celis, E., Quiceno, D. G., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., Gabrilovich, D. I. (2010) HIF-1a regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207, 2439-2453.
57. Sagiv, J. Y., Michaeli, J., Assi, S., Mishalian, I., Kisos, H., Levy, L., Damti, P., Lumbroso, D., Polyansky, L., Sionov, R. V., Ariel, A., Hovav, A. H., Henke, E., Fridlender, Z. G., Granot, Z. (2015) Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Reports 10, 562-573.
58. Grizzle, W. E., Xu, X., Zhang, S., Stockard, C. R., Liu, C., Yu, S., Wang, J., Mountz, J. D., Zhang, H. G. (2007) Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice. Mech. Ageing Dev. 128, 672-680.
59. Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., Weiss, S. (2010) Neutrophils responsive to endogenous IFN-b regulate tumor angiogenesis and growth in a mouse tumor model. J. Clin. Invest. 120, 1151-1164.
60. Li, H., Han, Y., Guo, Q., Zhang, M., Cao, X. (2009) Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-b 1. J. Immunol. 182, 240-249.
61. Simpson, K. D., Templeton, D. J., Cross, J. V. (2012) Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment. J. Immunol. 189, 5533-5540.
62. Liu, B. Y., Soloviev, I., Chang, P., Lee, J., Huang, X., Zhong, C., Ferrara, N., Polakis, P., Sakanaka, C. (2010) Stromal cell-derived factor-1/CXCL12 contributes to MMTV-Wnt1 tumor growth involving Gr1+CD11b+ cells. PLoS One 5, e8611.
63. Srivastava, M. K., Zhu, L., Harris-White, M., Kar, U. K., Huang, M., Johnson, M. F., Lee, J. M., Elashoff, D., Strieter, R., Dubinett, S., Sharma, S. (2012) Myeloid suppressor cell depletion augments antitumor activity in lung cancer. PLoS One 7, e40677